TrialLeukemia2020

Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment.

David S Siegel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.